Cubist Systematic Strategies, LLC Relmada Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.1 - $6.8 $158,599 - $347,894	51,161 New	51,161 $237,000
Q2 2023 Aug 14, 2023	SELL	$2.22 - $3.54 $48,893 - $77,964	-22,024 Reduced 58.73%	15,477 $38,000
Q1 2023 May 15, 2023	SELL	$2.24 - $4.76 $7,143 - $15,179	-3,189 Reduced 7.84%	37,501 $84,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $12,076 - $199,449	5,565 Added 15.84%	40,690 $142,000
Q3 2022 Nov 14, 2022	SELL	$18.3 - $37.02 $113,313 - $229,227	-6,192 Reduced 14.99%	35,125 $1.3 Million
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $125,169 - $230,159	7,586 Added 22.49%	41,317 $785,000
Q1 2022 May 16, 2022	BUY	$16.72 - $26.99 $548,783 - $885,865	32,822 Added 3610.78%	33,731 $910,000
Q4 2021 Feb 14, 2022	SELL	$16.93 - $26.82 $222,646 - $352,709	-13,151 Reduced 93.53%	909 $20,000
Q3 2021 Nov 15, 2021	BUY	$21.86 - $34.77 $280,704 - $446,481	12,841 Added 1053.4%	14,060 $369,000
Q2 2021 Aug 16, 2021	BUY	$29.55 - $39.15 $35,164 - $46,588	1,190 Added 4103.45%	1,219 $39,000
Q1 2021 May 17, 2021	SELL	$31.52 - $39.28 $18,754 - $23,371	-595 Reduced 95.35%	29 $1,000
Q4 2020 Feb 16, 2021	SELL	$29.88 - $39.8 $9,382 - $12,497	-314 Reduced 33.48%	624 $20,000
Q3 2020 Nov 16, 2020	BUY	$34.42 - $43.78 $32,285 - $41,065	938 New	938 $35,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.